Treatment of MRSA-infected osteomyelitis using bacterial capturing, magnetically targeted composites with microwave-assisted bacterial killing

Nat Commun. 2020 Sep 7;11(1):4446. doi: 10.1038/s41467-020-18268-0.

Abstract

Owing to the poor penetration depth of light, phototherapy, including photothermal and photodynamic therapies, remains severely ineffective in treating deep tissue infections such as methicillin-resistant Staphylococcus aureus (MRSA)-infected osteomyelitis. Here, we report a microwave-excited antibacterial nanocapturer system for treating deep tissue infections that consists of microwave-responsive Fe3O4/CNT and the chemotherapy agent gentamicin (Gent). This system, Fe3O4/CNT/Gent, is proven to efficiently target and eradicate MRSA-infected rabbit tibia osteomyelitis. Its robust antibacterial effectiveness is attributed to the precise bacteria-capturing ability and magnetic targeting of the nanocapturer, as well as the subsequent synergistic effects of precise microwaveocaloric therapy from Fe3O4/CNT and chemotherapy from the effective release of antibiotics in infection sites. The advanced target-nanocapturer of microwave-excited microwaveocaloric-chemotherapy with effective targeting developed in this study makes a major step forward in microwave therapy for deep tissue infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Drug Delivery Systems / methods
  • Drug Therapy / methods
  • Ferrosoferric Oxide / therapeutic use
  • Gentamicins / therapeutic use
  • Magnetite Nanoparticles / therapeutic use*
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Microwaves / therapeutic use*
  • Nanotubes, Carbon
  • Osteomyelitis / drug therapy*
  • Osteomyelitis / microbiology
  • Rabbits
  • Staphylococcal Infections / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Magnetite Nanoparticles
  • Nanotubes, Carbon
  • Ferrosoferric Oxide